Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351713A1 Anti-tenascin monoclonal antibody therapy for lymphoma
10/15/2003EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/15/2003EP1351707A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/15/2003EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
10/15/2003EP0805161B1 (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody
10/15/2003EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003EP0585398B1 Hcv genomic sequences for diagnostics and therapeutics
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449440A Masp-2, a complement-fixing enzyme, and uses for it
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449409A Promyostatin peptides and methods of using same
10/15/2003CN1448509A Human ICAM-1 extramembranous I-III domain gene expression product ,its prep. and application in radioimmunological technology
10/15/2003CN1448407A Production process of human immunoglobulin for intravenous injection
10/15/2003CN1448403A Human protein with cancer cell growth suppressing function and its coding sequence
10/15/2003CN1448402A Polypeptide-human anemia related protein 35.4 and polynucleotide for coding said polypeptide
10/15/2003CN1124343C Brain derived naurotrophic factor
10/15/2003CN1124284C High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
10/14/2003US6632976 Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
10/14/2003US6632937 Nucleic acids and proteins from Cenarchaeum symbiosum
10/14/2003US6632928 Immunotoxins and methods of inducing immune tolerance
10/14/2003US6632927 Complementary determining region grafted antibody heavy chain with a variable region domain of acceptor framework and donor antigen binding regions
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632667 Using a antisense oligonucleotides targeted to a untranslated region or a stop codon region of a nucleic acid; use in treatment of Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis, pancreatitis and asthma
10/14/2003US6632634 Decay accelerating factor (DAF) and nucleic acid encoding it
10/14/2003US6632624 Use immunoassay for precise measurement of levels of intact chromogranin A and the levels of major fragments found in circulating blood
10/14/2003US6632620 Use of monoclonal antibodies selectively binding ecto- and endodermally-derived stem cells for diagnosis of neoplasm and /or treat pathological conditions defined by abnormal/insuf-ficient function of differentiated cells of a mature organ
10/14/2003US6632614 Method for detecting anti-Streptococcus pyogenes DNase B antibody in a test sample
10/14/2003US6632437 Immunogenic polysaccharide-protein conjugates containing poly α(2→8), α(2→9) NeuNAc capsular polysaccharides
10/14/2003US6632434 Leptospiral major outer membrane protein, LipL 32
10/14/2003US6632432 Plasma from donors immunized with Staphylococcal epidermidis vaccine comprising antigens in TCA (trichloroacetic acid) extractions
10/14/2003US6632431 Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/09/2003WO2003083485A2 Protein for use in hypoxia related conditions
10/09/2003WO2003083115A1 Abc transporter-associated gene abcc13
10/09/2003WO2003083077A2 Antibody libraries
10/09/2003WO2003083072A2 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states
10/09/2003WO2003083071A2 Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
10/09/2003WO2003083069A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
10/09/2003WO2003083064A2 Chimeric pancreas
10/09/2003WO2003083062A2 Anti-il-tif antibodies and methods of using in inflammation
10/09/2003WO2003083061A2 Anti-tnf antibodies, compositions, methods and uses
10/09/2003WO2003083059A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083057A2 Adipocytes and uses thereof
10/09/2003WO2003083041A2 Cripto-specific antibodies
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082922A1 Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
10/09/2003WO2003082330A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
10/09/2003WO2003082329A2 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/09/2003WO2003082328A1 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082258A1 Use of cyr61 for the diagnosis of acute renal failure
10/09/2003WO2003082206A2 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
10/09/2003WO2003082006A2 Methods and compositions for preventing obesity and obesity related disorders
10/09/2003WO2003081993A2 Transgenic aves producing human polyclonal antibodies
10/09/2003WO2003081992A2 The functional disruption of avian immunoglobulin genes
10/09/2003WO2003047620A3 Compositions and methods for producing vascular occlusion
10/09/2003WO2003046558A3 Complement c3 precursor biopolymer markers predictive of type ii diabetes
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003030835A3 Use of bispecific antibodies to regulate immune responses
10/09/2003WO2003028432A3 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
10/09/2003WO2003026493A3 Diagnosis and treatment of diseases caused by mutations in cd72
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003016341A3 Regulation of iron uptake
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006893A3 Methods of inhibiting amyloid toxicity
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002092011A3 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002086096A3 Methods of producing or identifying intrabodies in eukaryotic cells
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2002065126A3 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
10/09/2003WO2002060955A3 Modified antibodies and methods of use
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002050123A3 Stabilization of antibodies or fragments thereof
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016612A3 Genes and proteins, and their uses
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191283 Nsp molecules
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
1 ... 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 ... 1494